94
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK

, , &
Pages 805-815 | Accepted 16 Feb 2005, Published online: 25 Apr 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Athanasios Pallis, Vasiliki Tsiantou, Efi Simou & Nikos Maniadakis. (2010) Pharmacoeconomic considerations in the treatment of breast cancer. ClinicoEconomics and Outcomes Research 2, pages 47-61.
Read now

Articles from other publishers (9)

Jackie M. Wypij & David A. Heller. (2014) Pamidronate Disodium for Palliative Therapy of Feline Bone-Invasive Tumors. Veterinary Medicine International 2014, pages 1-8.
Crossref
Roger von Moos, Cora Sternberg, Jean-Jacques Body & Carsten Bokemeyer. (2013) Reducing the burden of bone metastases. Supportive Care in Cancer 21:6, pages 1773-1783.
Crossref
Matti S. Aapro & Robert E. Coleman. (2012) Bone health management in patients with breast cancer: Current standards and emerging strategies. The Breast 21:1, pages 8-19.
Crossref
J. Félix, V. Andreozzi, M. Soares, P. Borrego, H. Gervásio, A. Moreira, L. Costa, F. Marcelo, F. Peralta, I. Furtado, F. Pina, C. Albuquerque, A. Santos & J.L. Passos-Coelho. (2011) Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer: Estimation for the Portuguese National Health System. Value in Health 14:4, pages 499-505.
Crossref
Dyfrig A. Hughes, Lesley Tilson & Michael Drummond. (2009) Estimating Drug Costs in Economic Evaluations in Ireland and the UK. PharmacoEconomics 27:8, pages 635-643.
Crossref
Per E. Lønning. (2008) Endocrine Therapy and Bone Loss in Breast Cancer: Time to Close in the RANK(L)?. Journal of Clinical Oncology 26:30, pages 4859-4861.
Crossref
A Paterson, E McCloskey, J Redzepovic, I Ott & R Gust. (2008) Cost-effectiveness of Oral Clodronate Compared with Oral Ibandronate, Intravenous Zoledronate or Intravenous Pamidronate in Breast Cancer Patients. Journal of International Medical Research 36:3, pages 400-413.
Crossref
Sohita Dhillon & Katherine A Lyseng-Williamson. (2008) Zoledronic Acid. Drugs 68:4, pages 507-534.
Crossref
M. Botteman, V. Barghout, J. Stephens, J. Hay, J. Brandman & M. Aapro. (2006) Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases. Annals of Oncology 17:7, pages 1072-1082.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.